{"id":99091,"date":"2019-11-27T18:22:38","date_gmt":"2019-11-28T02:22:38","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/11\/fda-calls-psychedelic-psilocybin-a-breakthrough-therapy-for-severe-depression"},"modified":"2019-11-27T18:22:38","modified_gmt":"2019-11-28T02:22:38","slug":"fda-calls-psychedelic-psilocybin-a-breakthrough-therapy-for-severe-depression","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/11\/fda-calls-psychedelic-psilocybin-a-breakthrough-therapy-for-severe-depression","title":{"rendered":"FDA Calls Psychedelic Psilocybin a \u2018Breakthrough Therapy\u2019 for Severe Depression"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/fda-calls-psychedelic-psilocybin-a-breakthrough-therapy-for-severe-depression2.jpg\"><\/a><\/p>\n<p>The FDA is helping to speed up the process of researching and approving <a href=\"https:\/\/www.livescience.com\/60687-magic-mushrooms-might-ease-depression.html\">psilocybin<\/a>, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).<\/p>\n<p>For the second time in a year, the U.S. Food and Drug Administration (FDA) has designated psilocybin therapy \u2014 currently being tested in clinical trials \u2014 as \u201cbreakthrough therapy,\u201d an action that is meant to accelerate the typically sluggish process of drug development and review. It is typically requested by a drug company and granted only when preliminary evidence suggests the drug may be an enormous improvement over already available therapy, according to the FDA.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD). For the second time in a year, the U.S. Food and Drug Administration (FDA) has designated psilocybin therapy \u2014 currently being tested in clinical trials \u2014 as \u201cbreakthrough therapy,\u201d [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-99091","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/99091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=99091"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/99091\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=99091"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=99091"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=99091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}